Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial

German Federal Ministry of Research, Technology and Space, UK Department of Health and Social Care as part of the Global Antimicrobial Resistance Innovation Fund, Japan Ministry of Health, Labour and Welfare, Netherlands Ministry of Health, Welfare and Sport and Directorate-General for International Cooperation, Switzerland Federal Office of Public Health, and the Canton of Geneva, Switzerland.

Authors

Institutions

Publication Details

Journal
The Lancet
Published
2025-12-11
DOI
https://doi.org/10.1016/s0140-6736(25)01953-1
Citations
10
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
11.83
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial

Subasree Srinivasan, Vimla Naicker, Stephanie E. Cohen, Magnus Unemo et al.
10 citations
The Lancet
Reproductive tract infections research
11.83
article

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial

Subasree Srinivasan, Vimla Naicker, Stephanie E. Cohen, Magnus Unemo, Drew Lewis, Katherine Gill, Chris Kenyon, Elizabeth Spooner, Stephanie N. Taylor, Nittaya Phanuphak, John P. Mueller, Manica Balasegaram, Teresa A. Batteiger, Edward W. Hook, Henry J.C. de Vries, Jodie Dionne‐Odom, Lindley A. Barbee, Helen Broadhurst, Rossaphorn Kittiyaowamarn, Zinhle Zwane, John P. O’Donnell, Seamus O’Brien, Alison Luckey, Sinead Delany‐Moretlwe
article en
10 citations

Abstract

German Federal Ministry of Research, Technology and Space, UK Department of Health and Social Care as part of the Global Antimicrobial Resistance Innovation Fund, Japan Ministry of Health, Labour and Welfare, Netherlands Ministry of Health, Welfare and Sport and Directorate-General for International Cooperation, Switzerland Federal Office of Public Health, and the Canton of Geneva, Switzerland.

The LancetVol. 407(10524)
South African Medical Research Council (ZA), Ministry of Public Health (TH), Desmond Tutu HIV Foundation (ZA), University of Cape Town (ZA), University of the Witwatersrand (ZA), University of Washington (US), University of Alabama at Birmingham (US), San Francisco Department of Public Health (US), HIV Netherlands Australia Thailand Research Collaboration (TH), Global Antibiotic Research & Development Partnership (CH), Setshaba Research Centre (ZA), Innoviva (United States) (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), Louisiana State University Health Sciences Center New Orleans (US), Instituut voor Tropische Geneeskunde (BE)
Openalex Percentile: Top 1%
Reproductive tract infections research
11.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.